Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: A new international initiative: Editorial

European Journal of Cancer Care

Volumn 18, Issue 2, 2009, Pages 105-107

  Bottomley, Andrew ^a   Quinten, Chantal ^a   Coens, Corneel ^a   Martinelli, Francesca ^a   Mauer, Murielle ^a   Maringwa, John ^a   Cleeland, Charles S ^b   Flechtner, Henning ^c   Gotay, Carolyn ^d   Greimel, Eva ^e   King, Madeleine ^f   Osoba, David ^g   Taphoorn, Martin J B ^h   Reeve, Bryce B ⁱ   Ringash, Jolie ^j   Schmucker Von Koch, Joseph ^k   Weis, Joachim ^l  

^a EORTC DATA CENTER   (Belgium)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY OF SYDNEY   (Australia)

^g Quality of Life Consulting   (Canada)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

^j UNIVERSITY OF TORONTO   (Canada)

^k UNIVERSITY OF REGENSBURG   (Germany)

^l UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

Cancer; Patient reported outcomes; Quality of life

Indexed keywords

HEALTH STATUS; HUMAN; INTERNATIONAL COOPERATION; NEOPLASM; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

HEALTH STATUS; HUMANS; INTERNATIONAL COOPERATION; NEOPLASMS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 61349159417     PISSN: 09615423     EISSN: 13652354     Source Type: Journal    
DOI: 10.1111/j.1365-2354.2009.01092.x     Document Type: Review

References (6)

1. Bottomley A. (2002) The cancer patient and quality of life. The Oncologist 7, 120 125.
2. Bottomley A. (2008) The journey of health-related quality of life assessment. The Lancet Oncology 9, 906.
3. Burke L.B., Kennedy D.L., Miskala P.H., Papadopoulos E.J. Trentacosti A.M. (2008) The use of patient-reported outcome measures in the evaluation of medical products for regulatory approval. Clinical Pharmacology & Therapeutics 84, 281 283.
4. Karnofsky D.A., Ablemann W.H., Craver L.F. Burchenal J.H. (1948) The use of the nitrogen mustards in palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1, 634 656.
5. Palmboom G.G., Willems D.L., Janssen N.B. de Haes J.C. (2007) Doctor's views on disclosing or withholding information on low risks of complication. Journal of Medical Ethics 33, 67 70.
6. Therasse P. (2005) Efficiency, quality and bureaucracy: not always in the same bag!! European Journal of Cancer 41, 2034.